Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis

A Zullo, Cesare Hassan, A Andriani, F Cristofari, V De Francesco, E Ierardi, S Tomao, S Morini, D. Vaira

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Helicobacter pylori eradication is recognized as the initial therapy for gastric low-grade, B-cell, mucosa-associated lymphoid tissue (MALT) lymphoma. This study assesses (i) the H. pylori eradication rates for various first- and second-line and rescue therapies and (ii) the associated reinfection rates in patients.
Original languageEnglish
Pages (from-to)1932-1932-7; quiz 1938
JournalTHE AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume104
DOIs
Publication statusPublished - 2009
Externally publishedYes

Keywords

  • Drug Therapy, Combination
  • Helicobacter Infections
  • Helicobacter pylori
  • Humans
  • Lymphoma, B-Cell, Marginal Zone
  • Recurrence
  • Statistics as Topic
  • Stomach Neoplasms

Fingerprint

Dive into the research topics of 'Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis'. Together they form a unique fingerprint.

Cite this